ReActive Robotics GmbH

Based in Munich, Germany, ReActive Robotics GmbH develops advanced robotic solutions to enhance rehabilitation processes, specifically for individuals with mobility impairments, facilitating recovery from neurological conditions. ReActive Robotics GmbH specializes in creating robotic exoskeletons that assist in rehabilitation for patients recovering from strokes and other mobility-related impairments. Founded in 2015 by Alexander Koenig, the company has undergone strategic pivots to focus on intelligent, assistive robotics. With its headquarters in Munich, Germany, ReActive Robotics has completed 3 funding deals, with the most recent round in April 2021, where it raised an undisclosed amount from investors including Bayern Kapital and Dr.

Doll Holding GmbH. ReActive Robotics specializes in the development of advanced robotic solutions that enhance rehabilitation processes for patients with mobility impairments. Their flagship product, a robotic exoskeleton, is designed to assist individuals recovering from strokes or other neurological conditions by providing targeted support and facilitating motor learning. This innovative device is tailored to the needs of both clinical environments and home rehabilitation, aiming to improve patient outcomes and independence.

The company primarily serves hospitals, rehabilitation centers, and home care agencies across North America and Europe, focusing on markets where there is a pressing demand for effective rehabilitation solutions. Through its partnerships with healthcare providers, ReActive Robotics ensures that their technology is integrated seamlessly into rehabilitation programs, fostering better patient engagement and recovery rates. ReActive Robotics generates revenue through direct sales and partnerships with healthcare institutions that utilize their robotic rehabilitation technologies. Transactions are structured as B2B agreements, where hospitals and rehabilitation centers purchase the robotic systems as part of their treatment offerings.

Clients typically engage in multi-year contracts that include maintenance services and software updates, ensuring the longevity and functionality of the devices. The pricing structure is designed to accommodate various healthcare budgets, reflecting the comprehensive support and training services that accompany the purchase of their products. As part of their service model, ReActive Robotics may also offer training modules for healthcare professionals, enhancing the integration of their technology into existing rehabilitation protocols. As of April 2021, ReActive Robotics GmbH raised an undisclosed amount of venture funding to support the development of intelligent, assistive robotics for early mobilization therapy, targeting both national and international markets.

The company plans to expand its product line and enhance its existing robotic exoskeletons to improve early mobilization efforts, focusing on intensive care patients. The recent funding will be instrumental in advancing these initiatives and addressing the growing demand for rehabilitation solutions.